Valeo Financial Advisors’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.42M Buy
22,551
+930
+4% +$99.9K 0.06% 151
2025
Q1
$2.18M Buy
21,621
+1,644
+8% +$166K 0.06% 144
2024
Q4
$1.78M Sell
19,977
-375
-2% -$33.5K 0.05% 163
2024
Q3
$1.71M Buy
20,352
+49
+0.2% +$4.11K 0.05% 172
2024
Q2
$1.56M Sell
20,303
-948
-4% -$73K 0.05% 175
2024
Q1
$1.55M Buy
21,251
+165
+0.8% +$12K 0.06% 176
2023
Q4
$1.22M Buy
21,086
+2,980
+16% +$172K 0.05% 197
2023
Q3
$956K Buy
18,106
+4,424
+32% +$234K 0.04% 214
2023
Q2
$740K Buy
13,682
+1,134
+9% +$61.3K 0.03% 246
2023
Q1
$628K Buy
12,548
+3,517
+39% +$176K 0.03% 287
2022
Q4
$418K Sell
9,031
-3,935
-30% -$182K 0.02% 310
2022
Q3
$502K Buy
+12,966
New +$502K 0.03% 258
2022
Q2
Sell
-5,843
Closed -$259K 506
2022
Q1
$259K Buy
5,843
+484
+9% +$21.5K 0.01% 455
2021
Q4
$228K Buy
5,359
+120
+2% +$5.11K 0.01% 465
2021
Q3
$227K Buy
5,239
+318
+6% +$13.8K 0.01% 444
2021
Q2
$210K Buy
4,921
+85
+2% +$3.63K 0.01% 411
2021
Q1
$187K Sell
4,836
-203
-4% -$7.85K 0.01% 442
2020
Q4
$181K Hold
5,039
0.01% 425
2020
Q3
$193K Sell
5,039
-306
-6% -$11.7K 0.02% 326
2020
Q2
$188K Sell
5,345
-155
-3% -$5.45K 0.02% 328
2020
Q1
$199K Sell
5,500
-1,104
-17% -$39.9K 0.02% 298
2019
Q4
$299K Buy
6,604
+490
+8% +$22.2K 0.03% 252
2019
Q3
$249K Buy
6,114
+1,741
+40% +$70.9K 0.03% 262
2019
Q2
$188K Hold
4,373
0.02% 299
2019
Q1
$168K Buy
4,373
+144
+3% +$5.53K 0.02% 315
2018
Q4
$149K Sell
4,229
-246
-5% -$8.67K 0.02% 300
2018
Q3
$162K Buy
4,475
+62
+1% +$2.24K 0.02% 306
2018
Q2
$147K Sell
4,413
-838
-16% -$27.9K 0.02% 334
2018
Q1
$143K Buy
5,251
+175
+3% +$4.77K 0.02% 295
2017
Q4
$126K Buy
5,076
+330
+7% +$8.19K 0.02% 301
2017
Q3
$138K Buy
+4,746
New +$138K 0.03% 243